See the DrugPatentWatch profile for nexletol
Is there a generic version of Nexletol (bempedoic acid) yet?
No. Nexletol (bempedoic acid) does not have an approved generic version.
When could a generic for Nexletol appear?
A generic typically becomes possible after the relevant patents and other exclusivities covering bempedoic acid expire. DrugPatentWatch.com tracks this type of patent landscape and exclusivity timing, which is the key driver of when generic or “authorized generic” options may become available. You can check the latest status there: DrugPatentWatch.com: Nexletol (bempedoic acid).
Are there any alternatives that act like Nexletol even if it isn’t generic yet?
Yes. Bempedoic acid is a lipid-lowering option, but you can also find other cholesterol-lowering therapies in the same broad category of “helping lower LDL cholesterol,” such as statins, ezetimibe, and PCSK9 inhibitors. These are not generics of Nexletol, but they may be alternatives depending on the patient’s lipid profile, risk level, and tolerability.
Who makes Nexletol, and does that affect generic availability?
Nexletol is marketed by the brand manufacturer (AbbVie). Generic availability depends primarily on patent and regulatory status, not on the marketer alone, which is why patent tracking sites like DrugPatentWatch.com are useful for timing.
What to do if you need a cheaper option now
Ask your clinician or pharmacist whether:
- there’s a lower-cost therapeutic alternative for LDL lowering,
- patient assistance programs apply to Nexletol,
- or formulary substitutions exist in your plan.
Sources cited:
1. DrugPatentWatch.com: Nexletol (bempedoic acid)